Elevated liver enzymes in Turner syndrome during a 5-year follow-up study
Article first published online: 27 DEC 2007
© 2008 The Authors
Volume 68, Issue 3, pages 485–490, March 2008
How to Cite
El-Mansoury, M., Berntorp, K., Bryman, I., Hanson, C., Innala, E., Karlsson, A. and Landin-Wilhelmsen, K. (2008), Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clinical Endocrinology, 68: 485–490. doi: 10.1111/j.1365-2265.2007.03166.x
- Issue published online: 27 DEC 2007
- Article first published online: 27 DEC 2007
- (Received 29 August 2007; returned for revision 1 October 2007; finally revised 9 November 2007; accepted 18 December 2007)
Objectives To study the prevalence and incidence of elevated liver enzymes and their relationship with body weight, metabolic factors and other diseases in Turner syndrome (TS).
Design Five-year follow-up.
Patients Women with TS (n = 218, mean age 33 ± 13, range 16–71 years) from outpatient clinics at university hospitals in Sweden.
Measurements Fasting blood samples for aspartate (AST) and alanine aminotransferase (ALT), bilirubin, alkaline phosphatase (ALP), γ-glutamyl transferase (GT), viral hepatitis serology and hepatic auto-antibodies, vitamin B12, blood glucose, lipids and hormones.
Results Seventy-nine subjects (36%) had one or more liver enzyme levels higher than the reference level, the most prevalent being GT. Karyotype 45,X was present in 51% of all TS women and in 48% of those with elevated liver enzymes. Body weight, body mass index (BMI), total cholesterol, triglycerides, and apolipoproteins A and B at start were higher in TS women with elevated liver enzymes than in TS women with normal levels. At 5 years, AST, ALT and GT were increased and another 23% of patients had developed elevated liver enzymes, that is, 59% in total (36% + 23%), while in 6%, the elevated liver enzymes had been normalized and all 6% also had lowered cholesterol levels. Multivariate analysis showed that GT was correlated with total cholesterol; P = 0·0032 at start and P = 0·0005 at 5 years, independently of other factors. Liver biopsy in six TS women showed one cholangitis, one hepatitis C, two steatosis and two normal biopsies. Withdrawal of oestrogen substitution did not influence the liver enzymes.
Conclusions Pathological liver enzymes were common in TS women, with a prevalence of 36% at 33 years of age, an annual incidence over 5 years of 3·4%. There was no relation to karyotype, alcohol, viral hepatitis, E2 or autoimmunity, but a connection with total serum cholesterol.